Biotech Fund Sells $12.3 Million in Crinetics Stock
MPM BioImpact has completely divested its stake in Crinetics Pharmaceuticals, as disclosed in a November 14 SEC filing. The fund ...
Tag: Crinetics
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.